Cardinal Health: Recall Of 267 Million Monoject Syringes May ‘Contribute To Market Disruption’
The recall of such a massive number of syringes could cause supply problems
Executive Summary
The prefilled saline syringes were recalled because they could “reintroduce air into the syringe after the air has been expelled,” the manufacturer explains. The US FDA on 23 August affixed its highest risk classification, class I, to the recall.